Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Inv. presentation
Director departure
|
|
MedAvail Holdings, Inc. (MDVL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/15/2023 |
SC 13D/A
| Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. reports a 29.6% stake in MedAvail Holdings, Inc. |
| 07/06/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/06/2022 |
SC 13D/A
| Redmile Group, LLC reports a 41.8% stake in MedAvail Holdings, Inc. |
| 04/06/2022 |
SC 13D/A
| Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. reports a 27.1% stake in MedAvail Holdings, Inc. |
| 01/14/2022 |
SC 13D/A
| Redmile Group, LLC reports a 34.3% stake in MedAvail Holdings, Inc. |
| 11/29/2021 |
SC 13D/A
| Redmile Group, LLC reports a 34.3% stake in MedAvail Holdings, Inc. |
| 07/20/2012 |
SC 13D/A
| Hariri Robert J reports a 11.8% stake in MYOS Corporation |
|
|